CONGRESS GUIDE

ERS International Congress 2016
T-24 Session 601 12:50 - 14:40
Thematic Poster: Asthma management
Chairs : Fusun Yildiz (KOCAEL , Turkey), Bilun Gemicioglu ( STANBUL, Turkey), Tania Maes (Ghent, Belgium), Mohamed Al-
Moamary (Riyadh, Saudi Arabia)
PA4106
DETAILED PROGRAMME
TUESDAY 06 SEPTEMBER, 2016
A weight-based exacerbation dose-response analysis of mepolizumab in severe asthma with eosinophilic phenotype
Isabelle Pouliquen (UXBRIDGE, United Kingdom), Isabelle Pouliquen, Daren Austin, Necdet Gunsoy, Steven Yancey
PA4107
PA4108
PA4109
PA4110
PA4111
PA4112
PA4113
PA4114
PA4115
PA4116
PA4117
PA4118
PA4119
PA4120
PA4121
PA4122
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5:
Analysis of two phase 3, placebo (PBO)-controlled trials
Guy Brusselle (Ghent, Belgium), Guy Brusselle, Jennifer McElhattan, Janice Canvin, Roland Buhl
SQ HDM SLIT-tablet is effective in patients not well-controlled in GINA treatment steps 2-4
Johann Christian Virchow (Rostock, Germany), Johann Christian Virchow, Victoria Cardona, Hanne Villesen, Christian
Ljørring, Bente Riis, Frederic de Blay
Fluticasone propionate/formoterol breath-triggered inhaler: Ease-of-use and patient preference
Mark Lomax (CAMBRIDGE, United Kingdom), David Bell, Lucielle Mansfield, Mark Lomax
MiRNA-183 cluster in response to asthma treatment
Aleksandra Divac Rankov (Belgrade, Republic of Serbia), Sandra Dragicevic, Vanja Radulovic, Natasa Anastasov, Michael
Atkinson, Dragica Radojkovic, Aleksandra Divac Rankov
Evaluation method of airways for asthma patients using low dose HRCT images
Levent Kart (Istanbul, Turkey), Emine Doganay, Levent Kart, Hatice Kutbay Özçelik, Sadik Kara
Vitamin D for the management of asthma: Cochrane systematic review and meta-analysis
Adrian R Martineau (London, United Kingdom), Adrian R. Martineau, Christopher J. Cates, Mitsuyoshi Urashima, Megan
Jensen, Alex P. Griffiths, Ulugbek Nurmatov, Aziz Sheikh, Christopher J. Griffiths
Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma
Pinja Ilmarinen (Seinäjoki, Finland), Pinja Ilmarinen, Leena E. Tuomisto, Onni Niemelä, Joanna Danielsson, Jussi Haanpää,
Terhi Kankaanranta, Hannu Kankaanranta
Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients
with persistent asthma
Jaideep Gogtay (Mumbai, Maharashtra, India), Pradyut Waghray, Mahip Saluja, Mayank Agarwal, Abhijit Vaidya, Jaideep
Gogtay, Ashish Kumar Deb, Sneha Limaye, Ashish Goyal, Aloke Gopal Ghoshal, Sudhir Bhatnagar, Akash Balki, George
Dsouza, Manish Kumar Jain, Sharad Tikkiwal, Sujeet Rajan, Raja Dhar
The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Caroline Gouder (Kappara, Malta), Caroline Gouder, Rachelle Asciak, Stephen Montefort
Effect of borago extract on moderate persistent asthma, a phase two randomized, double blind placebo-controlled
clinical trial
Majid Mirsadraei (MASHHAD, Islamic Republic of Iran), Majid Mirsadraee, Sara Khashkhashi Moghaddam, Parisa Saeidi
Total and free IgE in evolution of severe asthma after omalizumab treatment
Ebymar Arismendi Nunez (Barcelona, Spain), María del Carmen Vennera, Mariona Pascal, Ebymar Arismendi Nunez,
César Picado
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Olaf Schmidt (Koblenz, Germany), Olaf Schmidt, Frank Kanniess, Petra Oepen, Birgit Langer-Brauburger
Consumption of asthma and allergy drugs in Finland
Paula Kauppi (Helsinki, Finland), Paula Kauppi, Juha Jantunen, Jaana Martikainen, Mika Mäkelä, Tari Haahtela
Efficacy of omalizumab in Polish real-world patients
Agnieszka Gawlewicz-Mroczka (Kraków, Poland), Agnieszka Gawlewicz-Mroczka, Weronika Zastrzezynska, Marek
Przybyszowski, Adam Cmiel, Krzysztof Sladek
Audit of bronchial thermoplasty patients who did not complete their treatment session as planned
LJ Holmes (Manchester, United Kingdom), K. Hince, L.J. Holmes, G. McCumesky, C. Ustabasi, R.M. Niven, D. Ryan
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Antoine Poskin (Vilvoorde, Belgium), Alain Michils, Antoine Poskin, Jan Van Schoor, Stefaan Vancayzeele, Sandra
Gurdain, Muriel Lins
271 26.08.2016